Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
British Journal of Haematology
|
May 26, 2020
Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study
Dragana Milojkovic, Nicholas C P Cross, Sahra Ali, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 9, 2020
Distributed learning on 20 000+ lung cancer patients - The Personal Health Train
Timo M Deist, Frank J W M Dankers, Priyanka Ojha, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 3, 2013
'Rapid Learning health care in oncology' - an approach towards decision support systems enabling customised radiotherapy'
Philippe Lambin, Erik Roelofs, Bart Reymen, et al.
Clinical Pharmacology and Therapeutics
|
August 3, 2023
Model-Informed Drug Development: Steps Toward Harmonized Guidance
Scott Marshall, Malidi Ahamadi, Jenny Chien, et al.
Haematologica
|
December 1, 2020
Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial
Andrew R Pettitt, Richard Jackson, Silvia Cicconi, et al.
Peerj
|
September 8, 2016
The health care and life sciences community profile for dataset descriptions
Michel Dumontier, Alasdair J G Gray, M Scott Marshall, et al.
Blood Advances
|
September 12, 2024
Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy
Jad Othman, Angela Hwang, Maximillian Brodermann, et al.
Blood
|
August 30, 2023
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy
Jad Othman, Ing S Tiong, Jenny O'Nions, et al.
Nature Communications
|
January 29, 2021
Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia
Wei-Yu Lin, Sarah E Fordham, Nicola Sunter, et al.
Journal of Biomedical Semantics
|
February 6, 2014
BioHackathon series in 2011 and 2012: penetration of ontology and linked data in life science domains
Toshiaki Katayama, Mark D Wilkinson, Kiyoko F Aoki-Kinoshita, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
British Journal of Haematology
|
May 26, 2020
Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study
Dragana Milojkovic, Nicholas C P Cross, Sahra Ali, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 9, 2020
Distributed learning on 20 000+ lung cancer patients - The Personal Health Train
Timo M Deist, Frank J W M Dankers, Priyanka Ojha, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 3, 2013
'Rapid Learning health care in oncology' - an approach towards decision support systems enabling customised radiotherapy'
Philippe Lambin, Erik Roelofs, Bart Reymen, et al.
Clinical Pharmacology and Therapeutics
|
August 3, 2023
Model-Informed Drug Development: Steps Toward Harmonized Guidance
Scott Marshall, Malidi Ahamadi, Jenny Chien, et al.
Haematologica
|
December 1, 2020
Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial
Andrew R Pettitt, Richard Jackson, Silvia Cicconi, et al.
Peerj
|
September 8, 2016
The health care and life sciences community profile for dataset descriptions
Michel Dumontier, Alasdair J G Gray, M Scott Marshall, et al.
Blood Advances
|
September 12, 2024
Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy
Jad Othman, Angela Hwang, Maximillian Brodermann, et al.
Blood
|
August 30, 2023
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy
Jad Othman, Ing S Tiong, Jenny O'Nions, et al.
Nature Communications
|
January 29, 2021
Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia
Wei-Yu Lin, Sarah E Fordham, Nicola Sunter, et al.
Journal of Biomedical Semantics
|
February 6, 2014
BioHackathon series in 2011 and 2012: penetration of ontology and linked data in life science domains
Toshiaki Katayama, Mark D Wilkinson, Kiyoko F Aoki-Kinoshita, et al.
Page
of 9